The Journal of Nutritional Biochemistry
Volume 18, Issue 10 , Pages 637-649 , October 2007

Dietary factors and growth and metabolism in experimental tumors

Received 23 September 2006 ,Revised 6 December 2006 ,Accepted 28 December 2006.

References 

  1. In:  Cannon G editors. Food, nutrition and the prevention of cancer: a global perspective. Washington (DC): American Institute for Cancer Research; 1997;p. 1–670
  2. In:  Peter FM editors. Diet, nutrition and cancer. Washington (DC): National Academy Press; 1982;p. 1–478
  3. Simopoulos A, Robinson J. In: The Omega Diet. New York (NY): Harper Perennial; 1999;p. 1–382
  4. Drabsted LO, Strube M, Leith T. Dietary levels of plant phenols and other non-nutritive components: could they prevent cancer?. Eur J Cancer Prev. 1997;6:522–528
  5. Hill R, Song Y, Cardiff RD, Van Dyke T. Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell. 2005;123:1001–1011
  6. Galiè M, Sorrentino C, Montani M, Micossi L, Di Carlo E, D'Antuono T, et al. Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells. Carcinogenesis. 2005;26:1868–1878
  7. Gullino P, Grantham FH, Courtney AH. Glucose consumption by transplanted tumors in vivo. Cancer Res. 1967;27:1031–1040
  8. Sauer LA, Stayman JW, Dauchy RT. Amino acid, glucose and lactic acid utilization in vivo by rat tumors. Cancer Res. 1982;42:4090–4097
  9. Sauer LA, Dauchy RT. Ketone body, glucose, lactic acid, and amino acid utilization by tumors in vivo in fasted rats. Cancer Res. 1983;43:3497–3503
  10. Kallinowski F, Vaupel P, Runkel S, Berg G, Fortmeyer HP, Baessler KH, et al. Glucose uptake, lactate release, ketone body turnover, metabolic micromileau, and pH distribution in human breast cancer xenografts in nude rats. Cancer Res. 1988;48:7264–7272
  11. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 1989;49:6449–6465
  12. Sauer LA, Dauchy RT. Regulation of lactate production and utilization in rat tumors in vivo. J Biol Chem. 1985;260:7496–7501
  13. Sauer LA, Dauchy RT. Pathways of energy metabolism in cancer. In:  Watson RR,  Mufti SI editor. Nutrition and Cancer Prevention. Boca Raton (FL): CRC Press; 1996;p. 119–137
  14. Sauer LA, Dauchy RT. Lactate release and uptake in hepatoma 7288CTC perfused in situ with l-[(U)-14C]lactate or d-[(U)-14C]glucose. Metabolism. 1994;43:1488–1497
  15. Sauer LA, Dauchy RT. Stimulation of tumor growth in adult rats in vivo during acute streptozotocin-induced diabetes. Cancer Res. 1987;47:1756–1761
  16. Fenselau A, Wallis K, Morris HP. Subcellular localization of acetoacetate coenzyme A transferase in rat hepatomas. Cancer Res. 1976;36:4429–4443
  17. Richtsmeier WJ, Dauchy R, Sauer LA. In vivo nutrient uptake by head and neck cancers. Cancer Res. 1987;47:5230–5233
  18. Sauer LA, Dauchy RT. Uptake of plasma lipids by tissue-isolated hepatomas 7288CTC and 7777 in vivo. Br J Cancer. 1992;66:290–296
  19. Sauer LA, Dauchy RT. The effect of omega-6 and omega-3 fatty acids on [3H]-thymidine incorporation in hepatoma 7288CTC perfused in situ. Br J Cancer. 1992;66:297–303
  20. Dauchy RT, Sauer LA, Blask DE, Vaughan GM. Light contamination during the dark phase in “photoperiodically controlled” animal rooms: effect on tumor growth and metabolism in rats. Lab Anim Sci. 1997;47:511–518
  21. Sauer LA, Dauchy RT, Blask DE. Dietary linoleic acid intake controls the arterial blood plasma concentration and the rates of growth and linoleic acid uptake and metabolism in hepatoma 7288CTC in Buffalo rats. J Nutr. 1997;127:1412–1421
  22. Dauchy RT, Blask DE, Sauer LA, Brainard GC, Krause JA. Dim light during darkness stimulates tumor progression by enhancing tumor fatty acid uptake and metabolism. Cancer Lett. 1999;144:131–136
  23. Sauer LA, Dauchy RT, Blask DE, Armstrong BJ, Scalisi S. 13-Hydroxyoctadecadienoic acid is the mitogenic signal for linoleic acid-dependent growth in rat hepatoma 7288CTC in vivo. Cancer Res. 1999;59:4688–4692
  24. Blask DE, Sauer LA, Dauchy RT, Holowachuk EW, Ruhoff MS, Kopff HS. Melatonin inhibition of cancer growth in vivo involves suppression of tumor fatty acid metabolism via melatonin receptor-mediated signal transduction events. Cancer Res. 1999;59:4693–4701
  25. Sauer LA, Dauchy RT, Blask DE, Krause JA, Davidson LK, Dauchy EM, et al. Conjugated linoleic acid isomers and trans fatty acids inhibit fatty acid transport in hepatoma 7288CTC and inguinal fat pads in Buffalo rats. J Nutr. 2004;134:1989–1997
  26. Blask DE, Dauchy RT, Sauer LA, Krause JA. Melatonin uptake and growth prevention in rat hepatoma 7288CTC in response to dietary melatonin: melatonin receptor-mediated inhibition of tumor linoleic acid metabolism to the growth signaling molecule 13-hydroxyoctadecadienoic acid and the potential role of phytomelatonin. Carcinogenesis. 2004;25:951–960
  27. Blask DE, Brainard GC, Dauchy RT, Hanifin JP, Davidson LK, Krause JA, et al. Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats. Cancer Res. 2005;65:11174–11184
  28. Blask DE, Dauchy RT, Sauer LA, Krause JA, Brainard GC. Growth and fatty acid metabolism of human breast cancer (MCF-7) xenografts in nude rats: impact of constant light-induced nocturnal melatonin suppression. Breast Cancer Res Treat. 2003;79:313–320
  29. Sauer LA, Dauchy RT, Blask DE, Krause JA, Davidson LK, Dauchy EM. Eicosapentaenoic acid suppresses cell proliferation in MCF-7 human breast cancer xenografts in nude rats via a pertussis toxin-sensitive signal transduction pathway. J Nutr. 2005;135:2124–2129
  30. Dauchy RT, Dauchy EM, Sauer LA, Blask DE, Davidson LK, Krause JA, et al. Differential inhibition of fatty acid transport in tissue-isolated steroid receptor negative human breast cancer xenografts perfused in situ with isomers of conjugated linoleic acid. Cancer Lett. 2004;209:7–15
  31. Sauer LA, Nagel WO, Dauchy RT, Miceli LA, Austin JE. Stimulation of tumor growth in adult rats in vivo during an acute fast. Cancer Res. 1986;46:3469–3475
  32. Sauer LA, Dauchy RT. Blood nutrient concentrations and tumor growth in vivo in rats: relationships during the onset of an acute fast. Cancer Res. 1987;47:1065–1068
  33. Sauer LA, Dauchy RT. Identification of linoleic and arachidonic acids as the factors in hyperlipemic blood that increase [3H]thymidine incorporation in hepatoma 7288CTC perfused in situ. Cancer Res. 1988;48:3106–3111
  34. Shapot VS. On the multiform relationships between tumor and the host. Adv Cancer Res. 1979;30:89–150
  35. Fenninger LD, Mider GB. Energy and nitrogen metabolism in cancer. Adv Cancer Res. 1954;2:229–253
  36. Watson AF, Mellanby E. Tar cancer in mice: II. The condition of the skin when modified by external treatment or diet, as a factor in influencing the cancerous reaction. Br J Exp Pathol. 1930;11:311–322
  37. Tannenbaum A. The genesis and growth of tumors: III. Effects of a high-fat diet. Cancer Res. 1942;2:468–475
  38. Rao GA, Abraham S. Enhanced growth rate of transplanted mammary adenocarcinoma in C3H mice by dietary linoleate. J Natl Cancer Inst. 1976;56:431–432
  39. Rose DP, Hatala MA, Connolly JM, Rayburn J. Effect of diets containing different levels of linoleic acid on human breast cancer growth and lung metastasis in nude mice. Cancer Res. 1993;53:4686–4690
  40. Ip C, Carter CA, Ip MM. Requirement of essential fatty acid for mammary tumorigenesis in the rat. Cancer Res. 1985;45:1997–2001
  41. Roebuck BD, Longnecker DS, Baumgartner KJ, Thron CD. Carcinogen-induced lesions in the rat pancreas: effects of varying levels of essential fatty acid. Cancer Res. 1985;45:5252–5256
  42. Reddy BS, Sugie S. Effect of different levels of omega-3 and omega-6 fatty acids on azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Res. 1988;48:6642–6647
  43. Cohen LA, Thompson DO, Choi K, Karmali RA, Rose DP. Dietary fat and mammary cancer: II. Modulation of serum and tumor lipid composition and tumor prostaglandins by different dietary fats: Association with tumor incidence patterns. J Natl Cancer Inst. 1986;77:43–51
  44. Hillyard LA, Abraham S. Effect of dietary polyunsaturated fatty acids on growth of mammary carcinomas in mice and rats. Cancer Res. 1979;39:4430–4437
  45. Fay MP, Freedman LS, Clifford CK, Midthune DN. Effect of different types of amounts of fat on the development of mammary tumor in rodents; a review. Cancer Res. 1997;57:3979–3988
  46. Smith LC, Dauchy EM, Dauchy RT, Sauer LA, Blask DE, Davidson LK, et al. Dietary fish oil deactivates a growth-promoting signaling pathway in hepatoma 7288CTC in Buffalo rats. Nutr Cancer. 2007;56:204–213
  47. Dauchy EM, Dauchy RT, Davidson LK, Lynch DT, Krause JA, Blue LM, et al. Human cancer xenograft perfusion in situ in rats: a new perfusion system that minimizes delivery time and maintains normal tissue physiology and responsiveness to growth-inhibitory agents. J Am Assoc Lab Animal Sci. 2006;45:38–44
  48. Sauer LA, Dauchy RT, Blask DE, Davidson LK, Krause JA, Dauchy EM. Rosiglitazone and eicosatetraynoic acid cause a dose-dependent growth inhibition of rat hepatoma 7288CTC via an inhibitory G protein-coupled suppression of MEK1/2 and ERK1/2 phosphorylation. FASEB J. 2005;19:A517.3
  49. Sauer LA, Dauchy RT, Blask DE. Mechanism for the antitumor and anticachectic effects of n-3 fatty acids. Cancer Res. 2000;60:5289–5295
  50. Karmali RA, Marsh J, Fuchs C. Effect of omega-3 fatty acids on growth of a mammary tumor. J Natl Cancer Inst. 1984;73:457–461
  51. Gabor H, Abraham S. Effect of dietary menhaden oil on tumor cell loss and the accumulation of mass of a transplantable mammary adenocarcinoma in BALB/c mice. J Natl Cancer Inst. 1986;76:1223–1229
  52. Rose DP, Connolly JM. Effects of dietary omega-3 fatty acids on human breast cancer growth and metastasis in nude mice. J Natl Cancer Inst. 1993;85:1743–1747
  53. Welsch CW, Oakley CS, Chang CC, Welsch MA. Suppression of growth by dietary fish oil of human breast carcinomas maintained in three different strains of immune-deficient mice. Nutr Cancer. 1993;20:119–127
  54. Bokoch GM, Katada T, Northrup JK, Hewlett EL, Gilman AG. Identification of the predominant substrate for ADP-ribosylation by islet activating protein. J Biol Chem. 1983;258:2072–2075
  55. Meyer RB, Miller JP. Analogs of cyclic AMP and cyclic GMP: general methods of synthesis and the relationship of structure to enzymic activity. Life Sci. 1974;14:1019–1040
  56. Blask DE, Sauer LA, Dauchy RT. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr Top Med Chem. 2002;2:113–132
  57. Reiter RJ, Tan DX, Burkhardt S, Manchester LC. Melatonin in plants. Nutr Rev. 2001;59:286–290
  58. Griinari JM, Bauman DE. Biosynthesis of conjugated linoleic acid and its incorporation into meat and milk in ruminants. In:  Yurawecz MP,  Mossoba MM,  Kramer JKG,  Pariza MW,  Nelson GJ editor. Advances in Conjugated Linoleic Acid Research. vol. 1:Champaign (IL): AOCS Press; 1999;p. 180–200
  59. Belury MA. Dietary conjugated linoleic acid in health, physiological effects and mechanisms of action. Annu Rev Nutr. 2002;22:505–531
  60. Chin SF, Liu W, Storkson JM, Ha YL, Pariza MW. Dietary sources of conjugated dienoic isomers of linoleic acid, a newly recognized class of anticarcinogens. J Food Compos Anal. 1992;5:185–197
  61. Ip C, Singh M, Thompson HJ, Scimeca JA. Conjugated linoleic acid suppresses mammary carcinogenesis and proliferation activity of the mammary gland. Cancer Res. 1994;54:1212–1215
  62. Visonneau S, Cesano A, Tepper SA, Scimeca JA, Santoli D, Kritchevsky D. Conjugated linoleic acid suppresses the growth of human breast adenocarcinoma cells in SCID mice. Anticancer Res. 1997;17:969–974
  63. Ritzenthaler KL, McGuire MK, Falen R, Shultz TD, Dasgupta N, McGuire MA. Estimation of conjugated linoleic acid intake by written dietary assessment methodologies underestimates actual intake evaluation by food duplicate methodology. J Nutr. 2001;131:1548–1554
  64. Eling TE, Glasgow WC. Cellular proliferation and lipid metabolism: importance of lipoxygenases in modulating growth factor-dependent mitogenesis. Cancer Metastasis Rev. 1994;13:397–410
  65. Schaffer JE. Fatty acid transport: the roads taken. Am J Physiol Endocrinol Metab. 2002;282:E239–E246
  66. Tong F, Black PN, Coleman RA, DiRusso CC. Fatty acid transport by vectorial acylation in mammals: roles played by different isoforms of rat long-chain acyl-CoA synthetases. Arch Biochem Biophys. 2006;447:46–52
  67. Glasgow WC, Hui R, Everhart AL, Jayawickreme SP, Angerman-Stewart J, Han B-B, et al. The linoleic acid metabolite, (13S)-hydroperoxyoctadecadienoic acid, augments the epidermal growth factor receptor signaling pathway by attenuation of the receptor dephosphorylation. J Biol Chem. 1997;272:19269–19276
  68. Zakim D. Fatty acids enter cells by simple diffusion. Proc Soc Exp Biol Med. 1996;212:5–14
  69. Kamp F, Guo W, Souto R, Pilch P, Corkey BE, Hamilton JA. Rapid flip-flop of oleic acid across the plasma membrane of adipocytes. J Biol Chem. 2003;278:7988–7995
  70. Cupp D, Kampf JP, Kleinfeld AM. Fatty acid–albumin complexes and the determination of the transport of long chain fatty acids across membranes. Biochemistry. 2004;43:4473–4481
  71. Kampf JP, Cupp D, Kleinfeld AM. Different mechanisms of free fatty acid flip-flop and dissociation revealed by temperature and molecular species dependence of transport across lipid vesicles. J Biol Chem. 2006;281:21566–21574
  72. DiRusso CC, Li H, Darwis D, Watkins PA, Berger J, Black PN. Comparative biochemical studies of the murine fatty acid transport proteins (FATP) expressed in yeast. J Biol Chem. 2005;280:16829–16837
  73. Tisdale MJ, Beck SA. Inhibition of tumour-induced lipolysis in vitro and cachexia and tumor growth in vivo by eicosapentaenoic acid. Biochem Pharmacol. 1991;41:103–107
  74. Price SA, Tisdale MJ. Mechanism of inhibition of tumor lipid-mobilizing factor by eicosapentaenoic acid. Cancer Res. 1998;58:4827–4831
  75. Kotarsky K, Nilsson NE, Flodgren E, Owman C, Olde B. A human cell surface receptor activated by free fatty acids and thiazolidinedione drugs. Biochem Biophys Res Commun. 2003;301:406–410
  76. Briscoe CP, Tadayyon M, Andrews JL, Benson WG, Chambers JK, Eilert MM, et al. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J Biol Chem. 2003;278:11303–11311
  77. Yonezawa T, Katoh K, Obara Y. Existence of GPR40 functioning in a human breast cancer cell line MCF-7. Biochem Biophys Res Commun. 2004;314:805–809
  78. Hardy S, St-Onge GG, Joly E, Langelier Y, Prentki M. Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40. J Biol Chem. 2005;280:13285–13291
  79. Hardy S, El- Assaad W, Przybytkowski E, Joly E, Prentki M, Langelier Y. Saturated fatty acid-induced apoptosis in MDA-MB-231 breast cancer cells. J Biol Chem. 2003;278:31861–31870
  80. Obinata H, Hattori T, Nakane S, Tatei K, Izumi T. Identification of 9-hydroxyoctadecadienoic acid and other oxidized free fatty acids as ligands of the G protein-coupled receptor G2A. J Biol Chem. 2005;280:40676–40683
  81. Hirasawa A, Tsumaya K, Awaji T, Katsuma S, Adachi T, Yamada M, et al. Free fatty acid regulate gut incretin glucogon-like peptide-1 secretion through GPR 120. Nat Med. 2005;11:90–94
  82. Kostenis E. A glance at G-protein-coupled receptors for lipid mediators: a growing receptor family with remarkably diverse ligands. Pharmacol Ther. 2004;102:243–257
  83. Hennig B, Lei W, Arzuaga X, Das Ghosh D, Saraswathi V, Toborek M. Linoleic acid induces proinflammatory events in vascular endothelial cells via activation of PI3K/Akt and ERK1/2 signaling. J Nutr Biochem. 2006;17:766–772
  84. Park HJ, Lee YW, Hennig B, Toborek M. Linoleic acid-induced VCAM-1 expression in human microvascular endothelial cells is mediated by the NF-kB-dependent pathway. Nutr Cancer. 2001;41:126–134
  85. Razanamahefa L, Prouff S, Bardon S. Stimulatory effect of arachidonic acid on T-47D human breast cancer cell growth is associated with enhancement of cyclin D1 mRNA expression. Nutr Cancer. 2000;38:274–280
  86. Albino AP, Juan G, Traganos F, Reinhart L, Connolly J, Rose DP. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation. Cancer Res. 2000;60:4139–4145
  87. Palakurthi SS, Flückinger R, Aktas H, Changolkar AK, Shahsafaei A, Harneit S, et al. Inhibition of translation initiation mediates the anticancer effect of the n-3 polyunsaturated fatty acid eicosapentaenoic acid. Cancer Res. 2000;60:2919–2925
  88. Barascu A, Besson P, Le Floch O, Bougnoux P, Jourdan M-L. CDK-1-cylin B1 mediates the inhibition of proliferation induced by omega-3 fatty acids in MDA-MD-231 breast cancer cells. Int J Biochem Cell Biol. 2006;38:196–208
  89. Sun H, Berquin IM, Edwards IJ. Omega-3 polyunsaturated fatty acids regulate syndecan-1 expression in human breast cancer cells. Cancer Res. 2005;65:4442–4447
  90. Narayanan BA, Narayanan JK, Simi B, Reddy BS. Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells. Cancer Res. 2003;63:972–979
  91. Calviello G, Di Nicuolo F, Gragnoli S, Piccioni E, Serini S, Maggiano N, et al. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1α induction pathway. Carcinogenesis. 2004;25:2303–2310
  92. Mirnikjoo B, Brown SE, Kim HFS, Marangell LB, Sweatt JD, Weeber EJ. Protein kinase inhibition by ω-3 fatty acids. J Biol Chem. 2001;276:10888–10896
  93. Cos S, Sanchez EJ. In vitro effects of melatonin on tumor cells. In:  Bartsch D,  Bartsch H,  Blask DE,  Cardinali DP,  Hrushesky WJM,  Mecke D editor. The Pineal Gland and Cancer. Berlin: Springer-Verlag; 2001;p. 221–239
  94. Martin V, Herrera F, Carrera-Gonzalez P, Garcia-Santos G, Antolin I, Rodriquez-Blanco J, et al. Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin. Cancer Res. 2006;66:1081–1088
  95. Lampen A, Leifheit M, Voss J, Nau H. Molecular and cellular effects of cis-9, trans-11-conjugated linoleic acid in enterocytes: effects on proliferation, differentiation, and gene expression. Biochim Biophy Acta. 2005;1735:30–40
  96. Ochoa JJ, Farquaharson AJ, Grant I, Moffat LE, Heys SD, Wahle KWJ. Conjugated linoleic acid (CLA's) decrease prostate cancer cell proliferation: different molecular mechanisms for cis-9, trans-11 and trans-10, cis-12 isomers. Carcinogenesis. 2004;25:1185–1191
  97. Kim J-H, Hubbard NE, Ziboh V, Erickson KL. Conjugated linoleic acid reduction of murine mammary tumor cell growth through 5-hydroxyeicosatetraenoic acid. Biochim Biophys Acta. 2005;1687:103–109
  98. Degner SC, Kemp MQ, Bowden GT, Romagnolo DF. Conjugated linoleic acid attenuates cyclooxygenase-2 transcriptional activity via an anti-AP-1 mechanism in MCF-7 breast cancer cells. J Nutr. 2006;136:421–427

PII: S0955-2863(07)00017-4

doi: 10.1016/j.jnutbio.2006.12.009

The Journal of Nutritional Biochemistry
Volume 18, Issue 10 , Pages 637-649 , October 2007

Article Tools

* Image Usage & Resolution